Send me real-time posts from this site at my email

Zentalis Pharmaceuticals appoints Kimberly Blackwell as top boss

Before joining ZNTL, Blackwell was chief medical officer at Tempus, a privately held data-providing precision medicine company. She was a vice president at Eli Lilly (LLY) prior to that. Anthony Sun will remain CEO of ZNTL's joint venture, Zentera Therapeutics. ZNTL also said board member Dave Johnson had been appointed as chairman. Separately, ZNTL on Monday priced its underwritten offering of 10.3M shares at an offering price of $19.38/SHARE for total gross proceeds of ~$200.2M. ZNTL stock +21.1% to $24.87 in morning trade.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue